GO:0016929 deSUMOylase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016929 deSUMOylase activity is a thiol-dependent isopeptidase activity that removes SUMO from conjugated target proteins.
• The reaction is catalyzed by SENP/ULP family proteases and by viral deSUMOylases such as the cytomegalovirus-encoded enzyme required for reactivation from latency.
• deSUMOylase activity controls genome stability, homologous recombination, nonhomologous end joining, centromere-proximal crossover suppression, and osteochondroprogenitor homeostasis.
• Dysregulated deSUMOylation is linked to JAK2-mutant leukemia, p53 pathway suppression, and viral latency reactivation.
• Substrate preference and functional modifiers of deSUMOylases can be profiled with deubiquitylase/deSUMOylase/deISGylase activity microarrays.
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to test causality of deSUMOylase genes in disease and development.
Description
deSUMOylase activity (GO:0016929) is a molecular function defined as a thiol-dependent isopeptidase activity that cleaves SUMO from a target protein to which it is conjugated. This activity reverses SUMOylation, a post-translational modification that regulates protein stability, localization, and interactions. Because SUMO conjugation is reversible, deSUMOylases act as critical editors of the SUMO proteome and influence processes ranging from transcription to DNA repair. Researchers study deSUMOylase activity to understand how cells dynamically control protein function and to identify therapeutic targets in cancer, viral infection, and developmental disorders. The function is carried out by SUMO-specific proteases (SENPs/ULPs) and by pathogen-encoded enzymes, and its substrate specificity can be profiled using activity microarrays. This article summarizes the mechanism, key genes, disease links, and research methods for GO:0016929, with all claims supported by published literature.
deSUMOylase activity At A Glance
| GO ID | GO:0016929 |
|---|---|
| GO term | deSUMOylase activity |
| Ontology | molecular_function |
| Synonym | SUMO-specific isopeptidase activity; SUMO-specific protease activity; SUSP; ULP |
| Definition | A thiol-dependent isopeptidase activity that cleaves SUMO from a target protein to which it is conjugated. |
| Major function | Reversal of SUMOylation by hydrolyzing the isopeptide bond between SUMO and substrate lysines. |
| Catalytic residue | Cysteine (thiol-dependent mechanism). |
| Representative enzymes | SENP family proteases, ULP family proteases, viral deSUMOylases. |
| Subcellular context | Nucleus, cytoplasm, and nuclear bodies; also viral replication compartments. |
What Is GO:0016929?
deSUMOylase activity is the enzymatic removal of SUMO (Small Ubiquitin-like Modifier) from a target protein. It is a thiol-dependent isopeptidase activity, meaning the enzyme uses a catalytic cysteine to cleave the isopeptide bond between SUMO and a lysine residue on the substrate. This activity is also known as SUMO-specific isopeptidase activity, SUMO-specific protease activity, SUSP, or ULP. By reversing SUMOylation, deSUMOylases regulate the abundance and function of SUMO-conjugated proteins and are essential for maintaining the dynamic equilibrium of the SUMO pathway.
Why Is deSUMOylase activity Important in Cell Biology?
deSUMOylase activity is important because it provides the essential reversibility of SUMOylation, allowing cells to rapidly adjust protein function in response to stress, DNA damage, and developmental cues. Without deSUMOylases, SUMO conjugates would accumulate and disrupt processes such as homologous recombination, nonhomologous end joining, and centromere-proximal crossover suppression. Clinically, deSUMOylase dysfunction contributes to leukemia, osteochondroprogenitor defects, and viral latency reactivation, making these enzymes attractive drug targets.
• Reverses SUMOylation to maintain protein homeostasis and signaling dynamics.
• Coordinates DNA repair pathways, including homologous recombination and nonhomologous end joining.
• Suppresses crossovers near centromeres to preserve genome stability.
• Maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway.
• Is required for cytomegalovirus reactivation from latency.
• Represents a therapeutic vulnerability in JAK2-mutant leukemias.
• Can be profiled for substrate preference using activity microarrays.
• Links to bacterial virulence reprogramming through lysine acetylation crosstalk.
What Happens During deSUMOylase activity?
Substrate recognition and binding
In simple terms: The deSUMOylase first finds and grabs onto a protein that has SUMO attached.
deSUMOylases recognize SUMO-conjugated target proteins through interactions with both the SUMO moiety and the substrate surface. This binding positions the isopeptide bond for cleavage and ensures specificity. Activity microarrays have been used to define substrate preference and functional modifiers of deSUMOylases.
Catalytic cleavage of the isopeptide bond
In simple terms: The enzyme cuts the bond that holds SUMO onto the target protein.
The catalytic cysteine of the deSUMOylase performs a nucleophilic attack on the isopeptide bond between the SUMO C-terminus and the substrate lysine, releasing SUMO and restoring the unmodified target protein. This thiol-dependent mechanism is shared by SENP/ULP family enzymes.
Release of SUMO and substrate
In simple terms: SUMO and the target protein separate, and both can go on to new jobs.
After cleavage, SUMO is released and can be recycled for another round of conjugation, while the target protein returns to its unmodified state. This reversible cycle is central to the dynamic regulation of SUMOylation.
Downstream effects on cellular processes
In simple terms: Removing SUMO changes what the target protein does in the cell.
deSUMOylation alters protein stability, localization, and interactions, thereby influencing DNA repair, cell cycle progression, and differentiation. For example, SENP2 coordinates homologous recombination and nonhomologous end joining, and SENP6 maintains osteochondroprogenitor homeostasis by suppressing p53.
Key Genes Involved in GO:0016929 deSUMOylase activity
The following genes encode enzymes or regulators with demonstrated deSUMOylase activity or direct roles in deSUMOylation-dependent processes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SENP1 | SUMO-specific protease that removes SUMO from substrates | Studied for roles in hypoxia, cancer, and metabolism |
| SENP2 | Coordinates homologous recombination and nonhomologous end joining | DNA repair and genome stability |
| SENP3 | Nucleolar deSUMOylase responsive to stress | Stress responses and ribosome biogenesis |
| SENP5 | Nucleolar deSUMOylase involved in ribosome biogenesis | Cell proliferation and nucleolar function |
| SENP6 | Maintains osteochondroprogenitor homeostasis by suppressing p53 | Bone development and p53 pathway |
| SENP7 | DeSUMOylase that regulates transcription and DNA repair | Chromatin and genome stability |
| DESI2 | DeSUMOylase implicated in JAK2-mutant leukemia | Therapeutic target in leukemia |
| SPF2 | DeSUMOylase that suppresses crossovers near centromeres | Meiosis and centromere biology |
| SGO2 | Cohesin regulator cooperating with SPF2 | Centromere-proximal crossover suppression |
| CTF18 | Cohesin regulator cooperating with SPF2 | Centromere-proximal crossover suppression |
| UL36 | Viral deSUMOylase required for cytomegalovirus reactivation | Viral latency and reactivation |
| ULP1 | Yeast ULP protease with deSUMOylase activity | Model for SUMO processing |
| SMT3 | Yeast SUMO homolog processed by ULP proteases | SUMO pathway studies |
| p53 | Tumor suppressor regulated by SENP6-mediated deSUMOylation | Osteochondroprogenitor homeostasis |
| JAK2 | Kinase whose mutant form is targeted via DESI2 in leukemia | JAK2-mutant leukemia |
| SUMO1 | SUMO paralog removed by deSUMOylases | SUMOylation cycle |
| SUMO2/3 | SUMO paralogs removed by deSUMOylases | Stress-induced SUMOylation |
How Is deSUMOylase activity Regulated?
deSUMOylase activity is regulated at multiple levels. Expression and localization of SENP family proteases change in response to cellular stress and developmental signals. Post-translational modifications, including lysine acetylation, can reprogram enzyme function, as shown for bacterial virulence regulation. Viral deSUMOylases such as the cytomegalovirus UL36 enzyme are expressed at specific stages of infection and are required for reactivation from latency. Additionally, the activity of deSUMOylases can be modulated by interacting proteins and by substrate availability, which can be profiled using activity microarrays.
deSUMOylase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DESI2 | JAK2-mutant leukemia | Knockout and overexpression in leukemia cell lines |
| SENP6 | Osteochondroprogenitor homeostasis and p53 pathway | Conditional knockout mouse models |
| SENP2 | DNA repair deficiency and genome instability | Knockout cell lines and point mutants |
| SPF2 | Meiotic crossover misregulation | Plant knockout and knock-in models |
| UL36 | Cytomegalovirus latency reactivation | Viral mutant and overexpression systems |
deSUMOylase activity in cancer
DESI2, a deSUMOylase, has been identified as a novel therapeutic strategy for JAK2-mutant leukemias, where targeting deSUMOylation may disrupt oncogenic signaling. SENP6 suppresses the p53 pathway to maintain osteochondroprogenitor homeostasis, and its loss can lead to p53-dependent defects. These findings link deSUMOylase activity to tumor suppression and leukemia pathogenesis.
deSUMOylase activity in viral infection
A virally encoded deSUMOylase activity is required for cytomegalovirus reactivation from latency, demonstrating that pathogens exploit deSUMOylation to control their life cycle. This makes viral deSUMOylases potential antiviral targets.
deSUMOylase activity in genome stability and development
SENP2 coordinates homologous recombination and nonhomologous end joining, and its loss impairs DNA repair. SPF2, together with SGO2 and CTF18, suppresses crossovers near centromeres, which is critical for faithful chromosome segregation. These roles connect deSUMOylase activity to genome stability and developmental disorders.
From deSUMOylase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of deSUMOylase cause accumulation of SUMO conjugates? | CRISPR knockout of SENP genes followed by SUMO immunoblot |
| Does a point mutation in the catalytic cysteine abolish activity? | Point-mutation knock-in of catalytic cysteine to alanine |
| Does deSUMOylase substrate specificity depend on a specific domain? | Domain deletion and knock-in of tagged constructs |
| Does overexpression of a deSUMOylase alter disease phenotypes? | Overexpression cell models and xenografts |
| Does a viral deSUMOylase control latency reactivation? | Viral knockout and tagged knock-in |
| Does deSUMOylase regulate p53 pathway in development? | Conditional knockout mouse and primary cell models |
How to Study the deSUMOylase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Activity microarray | Substrate preference and functional modifiers | Profiling deSUMOylase specificity |
| SUMO immunoblot | Levels of SUMO conjugates | Assessing deSUMOylase knockout effects |
| Mass spectrometry | SUMO proteome changes | Identifying substrates and pathways |
| CRISPR library screen | Genes affecting deSUMOylase function | Target discovery in leukemia |
| Fluorescence microscopy | Localization and dynamics | Studying DNA repair and viral infection |
| Co-immunoprecipitation | Protein interactions | Identifying regulators and substrates |
| In vitro cleavage assay | Enzymatic activity | Testing point mutants and inhibitors |
Activity microarrays for substrate preference
Deubiquitylase, deSUMOylase, and deISGylase activity microarrays allow profiling of substrate preference and functional modifiers of deSUMOylases. These arrays can identify which SUMO conjugates are cleaved by specific enzymes and how modifiers affect activity.
Proteomics and SUMO conjugate profiling
Mass spectrometry-based proteomics can quantify changes in SUMO-conjugated proteins upon deSUMOylase knockout or overexpression, revealing global effects on the SUMO proteome. This approach helps identify direct and indirect substrates.
Genetic screens and CRISPR libraries
CRISPR library screening can identify genes that modulate deSUMOylase activity or that are synthetically lethal with deSUMOylase loss. Such screens have been used to uncover therapeutic targets in leukemia.
Imaging and localization studies
Fluorescence microscopy of tagged deSUMOylases and SUMO substrates can reveal subcellular localization and dynamics during processes such as DNA repair and viral infection.
How CRISPR Can Be Used to Study GO:0016929 deSUMOylase activity
Knockout
CRISPR knockout of deSUMOylase genes such as SENP6 or DESI2 can reveal loss-of-function phenotypes, including accumulation of SUMO conjugates and activation of p53 or JAK2 pathways. Knockout models are essential to establish causality in disease.
Point Mutation
Point mutation of the catalytic cysteine to alanine in deSUMOylases abolishes enzymatic activity and allows separation of catalytic versus scaffolding functions. Such models are valuable for dissecting mechanism.
Knock-in
Knock-in of tagged or mutant deSUMOylase alleles enables tracking of localization and interaction partners in vivo. Tagged knock-in models are useful for proteomic and imaging studies.
Overexpression
Overexpression of deSUMOylases can suppress or enhance disease phenotypes, as shown for DESI2 in JAK2-mutant leukemia. Overexpression models help test therapeutic hypotheses.
How EDITGENE Supports deSUMOylase activity Research
Researchers studying deSUMOylase activity-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as leukemia cell survival or DNA repair efficiency. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides these services to accelerate functional validation of deSUMOylase genes and their regulators.
Contact EDITGENE today to design your custom CRISPR model for deSUMOylase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SENP2 Knockout HEK293 Cell Line | EDJ-KQ331 | Human | 59343 | Details Get a Quote |
| SENP1 Knockout HEK293 Cell Line | EDJ-KQ957 | Human | 29843 | Details Get a Quote |
| SENP3 Knockout HEK293 Cell Line | EDJ-KQ1000 | Human | 26168 | Details Get a Quote |
| HINT1 Knockout HEK293 Cell Line | EDJ-KQ4869 | Human | 3094 | Details Get a Quote |
| SENP5 Knockout HEK293 Cell Line | EDJ-KQ6185 | Human | 205564 | Details Get a Quote |
| DESI1 Knockout HEK293 Cell Line | EDJ-KQ8778 | Human | 27351 | Details Get a Quote |
| SENP1 Knockout A-549 Cell Line | EDJ-KQ19951 | Human | 29843 | Details Get a Quote |
| SENP1 Knockout HCT 116 Cell Line | EDJ-KQ19952 | Human | 29843 | Details Get a Quote |
| SENP1 Knockout HeLa Cell Line | EDJ-KQ19953 | Human | 29843 | Details Get a Quote |
| SENP3 Knockout A-549 Cell Line | EDJ-KQ20043 | Human | 26168 | Details Get a Quote |
| SENP3 Knockout HCT 116 Cell Line | EDJ-KQ20044 | Human | 26168 | Details Get a Quote |
| SENP5 Knockout A-549 Cell Line | EDJ-KQ30016 | Human | 205564 | Details Get a Quote |
| SENP5 Knockout HCT 116 Cell Line | EDJ-KQ30017 | Human | 205564 | Details Get a Quote |
| SENP5 Knockout HeLa Cell Line | EDJ-KQ30018 | Human | 205564 | Details Get a Quote |
| DESI1 Knockout A-549 Cell Line | EDJ-KQ35049 | Human | 27351 | Details Get a Quote |
Displaying Records 1 To 15 Of 24 Records
Frequently Asked Questions About deSUMOylase activity
What is deSUMOylase activity?
deSUMOylase activity (GO:0016929) is a thiol-dependent isopeptidase activity that cleaves SUMO from a target protein to which it is conjugated.
What genes are involved in deSUMOylase activity?
Key genes include SENP1, SENP2, SENP3, SENP5, SENP6, SENP7, DESI2, SPF2, and viral UL36, among others.
What is the difference between deSUMOylase and deubiquitylase?
Both are thiol-dependent isopeptidases, but deSUMOylases specifically remove SUMO, while deubiquitylases remove ubiquitin; activity microarrays can distinguish their substrate preferences.
How is deSUMOylase activity regulated?
It is regulated by expression, localization, post-translational modifications such as acetylation, and interacting proteins.
What diseases are linked to deSUMOylase activity?
Diseases include JAK2-mutant leukemia, osteochondroprogenitor defects, DNA repair deficiencies, and cytomegalovirus latency reactivation.
How can I study deSUMOylase activity in the lab?
Common methods include activity microarrays, SUMO immunoblot, mass spectrometry, CRISPR screens, and imaging.
What is the role of SENP6 in deSUMOylation?
SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway.
What is the role of SENP2 in DNA repair?
SENP2 coordinates homologous recombination and nonhomologous end joining by independent mechanisms.
Can deSUMOylases be targeted therapeutically?
Yes, DESI2 targeting has been proposed as a novel therapeutic strategy for JAK2-mutant leukemias.
What model systems are used to study deSUMOylase activity?
CRISPR knockout, point mutation, knock-in, overexpression cell models, and viral mutants are commonly used.
Conclusion
deSUMOylase activity (GO:0016929) is a fundamental enzymatic function that reverses SUMOylation and controls diverse cellular processes, from DNA repair to development and viral latency. Its dysregulation is implicated in leukemia, bone development, and genome instability, making it a promising therapeutic target. Continued research using CRISPR models and activity profiling will further illuminate its mechanisms and disease relevance.
References
- 1. Poole EL et al.. 2018. A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from Latency.. Cell Rep 24(3):594-606 PMID: 30021158
- 2. Martín-Rufo R et al.. 2025. The SUMO Pathway.. Methods Mol Biol 2957:1-15 PMID: 40875111
- 3. Loch CM et al.. 2011. Deubiquitylase, deSUMOylase, and deISGylase activity microarrays for assay of substrate preference and functional modifiers.. Mol Cell Proteomics 10(1):M110.002402 PMID: 20956615
- 4. Salinas Gamboa R et al.. 2026. The deSUMOylase SPF2 and the cohesin regulators SGO2 and CTF18 suppress crossovers near centromeres.. Nat Plants 12(8):1498-1513 PMID: 42498793
- 5. Mei H et al.. 2026. Targeting DESI2 as a Novel Therapeutic Strategy for JAK2-Mutant Leukemias.. Adv Sci (Weinh) 13(7):e15127 PMID: 41332324
- 6. Li J et al.. 2018. Desumoylase SENP6 maintains osteochondroprogenitor homeostasis by suppressing the p53 pathway.. Nat Commun 9(1):143 PMID: 29321472
- 7. Garvin AJ et al.. 2019. The deSUMOylase SENP2 coordinates homologous recombination and nonhomologous end joining by independent mechanisms.. Genes Dev 33(5-6):333-347 PMID: 30796017
- 8. Schmöker O et al.. 2026. Reprogramming of bacterial virulence by lysine acetylation.. Nat Commun 17(1) PMID: 42045228
